2 results
Approved WMOCompleted
The primary objective of this study is to evaluate the safety and antiviral efficacy, defined as the percentage of subjects with sustained virologic response 12 weeks post-dosing (SVR12; HCV RNA < LLOQ 12 weeks after the last dose of study…
Approved WMOCompleted
Primary ObjectiveThe primary objective is to show that fusion with the Valeo OL spacer produces similar improvement in MRDQ at all follow-up time points as compared to the same procedure with PEEK cages.Secondary ObjectivesTo show that the fusion…